Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1992 May;66(5):2631–2638. doi: 10.1128/jvi.66.5.2631-2638.1992

Expression of the Marek's disease virus (MDV) homolog of glycoprotein B of herpes simplex virus by a recombinant baculovirus and its identification as the B antigen (gp100, gp60, gp49) of MDV.

M Niikura 1, Y Matsuura 1, D Endoh 1, M Onuma 1, T Mikami 1
PMCID: PMC241016  PMID: 1313890

Abstract

A gene encoding a homolog of glycoprotein B of herpes simplex virus (gB homolog) has been identified on the Marek's disease virus (MDV) genome (L. J. N. Ross, M. Sanderson, S. D. Scott, M. M. Binns, T. Doel, and B. Milne, J. Gen. Virol. 70:1789-1804, 1989); however, the molecular and immunological characteristics of the gene product(s) are still not clear. In the present study, the gB homolog of MDV was expressed in insect cells by a recombinant baculovirus, and it was characterized to determine its molecular and antigenic properties. The expressed recombinant protein had three molecular sizes (88 to 110, 58, and 49 kDa) and was recognized by antisera from chickens inoculated with each of the three serotypes of MDV. By immunofluorescence analysis, it was shown that the protein was expressed in the cytoplasm and on the surface of the recombinant baculovirus-infected cells. The gB homolog of MDV was processed similarly to pseudorabies virus and varicella-zoster virus with respect to cleavage and the intramolecular disulfide bond between the cleaved products. Interestingly, the expressed protein reacted with monoclonal antibody M51, specific to the B antigen (gp100, gp60, gp49) of MDV, although the locations of the gene encoding the B antigen and of the gene encoding the gB homolog were reported to be different. Moreover, competitive experiments revealed that anti-gB homolog serum and monoclonal antibody M51 recognized the same molecules. From these results, the gB homolog and the B antigen of MDV seem to be the same glycoprotein.

Full text

PDF
2631

Images in this article

2633Image
on p.2633
2633Image
on p.2633
2634Image
on p.2634
2634Image
on p.2634
2635Image
on p.2635

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barber G. N., Clegg J. C., Lloyd G. Expression of the Lassa virus nucleocapsid protein in insect cells infected with a recombinant baculovirus: application to diagnostic assays for Lassa virus infection. J Gen Virol. 1990 Jan;71(Pt 1):19–28. doi: 10.1099/0022-1317-71-1-19. [DOI] [PubMed] [Google Scholar]
  2. Ben-Porat T., DeMarchi J. M., Lomniczi B., Kaplan A. S. Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies. Virology. 1986 Oct 30;154(2):325–334. doi: 10.1016/0042-6822(86)90458-7. [DOI] [PubMed] [Google Scholar]
  3. Binns M. M., Ross N. L. Nucleotide sequence of the Marek's disease virus (MDV) RB-1B A antigen gene and the identification of the MDV A antigen as the herpes simplex virus-1 glycoprotein C homologue. Virus Res. 1989 Apr;12(4):371–381. doi: 10.1016/0168-1702(89)90094-4. [DOI] [PubMed] [Google Scholar]
  4. Bishop G. A., Kümel G., Schwartz S. A., Glorioso J. C. Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins. J Virol. 1986 Jan;57(1):294–300. doi: 10.1128/jvi.57.1.294-300.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blacklaws B. A., Krishna S., Minson A. C., Nash A. A. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology. 1990 Aug;177(2):727–736. doi: 10.1016/0042-6822(90)90539-4. [DOI] [PubMed] [Google Scholar]
  6. Blacklaws B. A., Nash A. A., Darby G. Specificity of the immune response of mice to herpes simplex virus glycoproteins B and D constitutively expressed on L cell lines. J Gen Virol. 1987 Apr;68(Pt 4):1103–1114. doi: 10.1099/0022-1317-68-4-1103. [DOI] [PubMed] [Google Scholar]
  7. Butters T. D., Hughes R. C., Vischer P. Steps in the biosynthesis of mosquito cell membrane glycoproteins and the effects of tunicamycin. Biochim Biophys Acta. 1981 Feb 6;640(3):672–686. doi: 10.1016/0005-2736(81)90097-3. [DOI] [PubMed] [Google Scholar]
  8. Bzik D. J., Debroy C., Fox B. A., Pederson N. E., Person S. The nucleotide sequence of the gB glycoprotein gene of HSV-2 and comparison with the corresponding gene of HSV-1. Virology. 1986 Dec;155(2):322–333. doi: 10.1016/0042-6822(86)90196-0. [DOI] [PubMed] [Google Scholar]
  9. Bzik D. J., Fox B. A., DeLuca N. A., Person S. Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1. Virology. 1984 Mar;133(2):301–314. doi: 10.1016/0042-6822(84)90397-0. [DOI] [PubMed] [Google Scholar]
  10. Cai W. H., Gu B., Person S. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J Virol. 1988 Aug;62(8):2596–2604. doi: 10.1128/jvi.62.8.2596-2604.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cantin E. M., Eberle R., Baldick J. L., Moss B., Willey D. E., Notkins A. L., Openshaw H. Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5908–5912. doi: 10.1073/pnas.84.16.5908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chan W. L., Lukig M. L., Liew F. Y. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection. J Exp Med. 1985 Oct 1;162(4):1304–1318. doi: 10.1084/jem.162.4.1304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Coussens P. M., Velicer L. F. Structure and complete nucleotide sequence of the Marek's disease herpesvirus gp57-65 gene. J Virol. 1988 Jul;62(7):2373–2379. doi: 10.1128/jvi.62.7.2373-2379.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cranage M. P., Kouzarides T., Bankier A. T., Satchwell S., Weston K., Tomlinson P., Barrell B., Hart H., Bell S. E., Minson A. C. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J. 1986 Nov;5(11):3057–3063. doi: 10.1002/j.1460-2075.1986.tb04606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cui Z. Z., Lee L. F., Liu J. L., Kung H. J. Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells. J Virol. 1991 Dec;65(12):6509–6515. doi: 10.1128/jvi.65.12.6509-6515.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Davidson I., Malkinson M., Becker Y. Marek's disease virus serotype-1 antigens A and B and their unglycosylated precursors detected by Western blot analysis of infected cells. Virus Genes. 1988 Oct;2(1):5–18. doi: 10.1007/BF00569733. [DOI] [PubMed] [Google Scholar]
  17. Fitzpatrick D. R., Zamb T., Parker M. D., van Drunen Littel-van den Hurk S., Babiuk L. A., Lawman M. J. Expression of bovine herpesvirus 1 glycoproteins gI and gIII in transfected murine cells. J Virol. 1988 Nov;62(11):4239–4248. doi: 10.1128/jvi.62.11.4239-4248.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fukuchi K., Sudo M., Lee Y. S., Tanaka A., Nonoyama M. Structure of Marek's disease virus DNA: detailed restriction enzyme map. J Virol. 1984 Jul;51(1):102–109. doi: 10.1128/jvi.51.1.102-109.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Glorioso J., Kees U., Kümel G., Kirchner H., Krammer P. H. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes. J Immunol. 1985 Jul;135(1):575–582. [PubMed] [Google Scholar]
  20. Gong M., Ooka T., Matsuo T., Kieff E. Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB. J Virol. 1987 Feb;61(2):499–508. doi: 10.1128/jvi.61.2.499-508.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Guo P. X., Goebel S., Perkus M. E., Taylor J., Norton E., Allen G., Languet B., Desmettre P., Paoletti E. Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity. J Virol. 1990 May;64(5):2399–2406. doi: 10.1128/jvi.64.5.2399-2406.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hammerschmidt W., Conraths F., Mankertz J., Pauli G., Ludwig H., Buhk H. J. Conservation of a gene cluster including glycoprotein B in bovine herpesvirus type 2 (BHV-2) and herpes simplex virus type 1 (HSV-1). Virology. 1988 Aug;165(2):388–405. doi: 10.1016/0042-6822(88)90583-1. [DOI] [PubMed] [Google Scholar]
  23. Hirai K., Nakajima K., Ikuta K., Kirisawa R., Kawakami Y., Mikami T., Kato S. Similarities and dissimilarities in the structure and expression of viral genomes of various virus strains immunologically related to Marek's disease virus. Arch Virol. 1986;89(1-4):113–130. doi: 10.1007/BF01309883. [DOI] [PubMed] [Google Scholar]
  24. Ikuta K., Ueda S., Kato S., Hirai K. Identification with monoclonal antibodies of glycoproteins of Marek's disease virus and herpesvirus of turkeys related to virus neutralization. J Virol. 1984 Mar;49(3):1014–1017. doi: 10.1128/jvi.49.3.1014-1017.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ikuta K., Ueda S., Kato S., Hirai K. Monoclonal antibodies reactive with the surface and secreted glycoproteins of Marek's disease virus and herpesvirus of turkeys. J Gen Virol. 1983 Dec;64(Pt 12):2597–2610. doi: 10.1099/0022-1317-64-12-2597. [DOI] [PubMed] [Google Scholar]
  26. Ikuta K., Ueda S., Kato S., Hirai K. Processing of glycoprotein gB related to neutralization of Marek's disease virus and herpesvirus of turkeys. Microbiol Immunol. 1984;28(8):923–933. doi: 10.1111/j.1348-0421.1984.tb00748.x. [DOI] [PubMed] [Google Scholar]
  27. Isfort R. J., Kung H. J., Velicer L. F. Identification of the gene encoding Marek's disease herpesvirus A antigen. J Virol. 1987 Aug;61(8):2614–2620. doi: 10.1128/jvi.61.8.2614-2620.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Isfort R. J., Sithole I., Kung H. J., Velicer L. F. Molecular characterization of Marek's disease herpesvirus B antigen. J Virol. 1986 Aug;59(2):411–419. doi: 10.1128/jvi.59.2.411-419.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Isfort R. J., Stringer R. A., Kung H. J., Velicer L. F. Synthesis, processing, and secretion of the Marek's disease herpesvirus A antigen glycoprotein. J Virol. 1986 Feb;57(2):464–474. doi: 10.1128/jvi.57.2.464-474.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ishii H., Kobayashi Y., Kuroki M., Kodama Y. Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI. J Gen Virol. 1988 Jun;69(Pt 6):1411–1414. doi: 10.1099/0022-1317-69-6-1411. [DOI] [PubMed] [Google Scholar]
  31. Jarvis D. L., Summers M. D. Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells. Mol Cell Biol. 1989 Jan;9(1):214–223. doi: 10.1128/mcb.9.1.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kato S., Hirai K. Marek's disease virus. Adv Virus Res. 1985;30:225–277. doi: 10.1016/s0065-3527(08)60452-2. [DOI] [PubMed] [Google Scholar]
  33. Keller P. M., Davison A. J., Lowe R. S., Bennett C. D., Ellis R. W. Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus. Virology. 1986 Jul 15;152(1):181–191. doi: 10.1016/0042-6822(86)90383-1. [DOI] [PubMed] [Google Scholar]
  34. Keller P. M., Neff B. J., Ellis R. W. Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J Virol. 1984 Oct;52(1):293–297. doi: 10.1128/jvi.52.1.293-297.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kuroda K., Geyer H., Geyer R., Doerfler W., Klenk H. D. The oligosaccharides of influenza virus hemagglutinin expressed in insect cells by a baculovirus vector. Virology. 1990 Feb;174(2):418–429. doi: 10.1016/0042-6822(90)90095-9. [DOI] [PubMed] [Google Scholar]
  36. Little S. P., Jofre J. T., Courtney R. J., Schaffer P. A. A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1. Virology. 1981 Nov;115(1):149–160. doi: 10.1016/0042-6822(81)90097-0. [DOI] [PubMed] [Google Scholar]
  37. Maeda S., Kawai T., Obinata M., Fujiwara H., Horiuchi T., Saeki Y., Sato Y., Furusawa M. Production of human alpha-interferon in silkworm using a baculovirus vector. Nature. 1985 Jun 13;315(6020):592–594. doi: 10.1038/315592a0. [DOI] [PubMed] [Google Scholar]
  38. Manservigi R., Spear P. G., Buchan A. Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3913–3917. doi: 10.1073/pnas.74.9.3913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Matsuura Y., Miyamoto M., Sato T., Morita C., Yasui K. Characterization of Japanese encephalitis virus envelope protein expressed by recombinant baculoviruses. Virology. 1989 Dec;173(2):674–682. doi: 10.1016/0042-6822(89)90580-1. [DOI] [PubMed] [Google Scholar]
  40. Matsuura Y., Possee R. D., Bishop D. H. Expression of the S-coded genes of lymphocytic choriomeningitis arenavirus using a baculovirus vector. J Gen Virol. 1986 Aug;67(Pt 8):1515–1529. doi: 10.1099/0022-1317-67-8-1515. [DOI] [PubMed] [Google Scholar]
  41. Matsuura Y., Possee R. D., Overton H. A., Bishop D. H. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J Gen Virol. 1987 May;68(Pt 5):1233–1250. doi: 10.1099/0022-1317-68-5-1233. [DOI] [PubMed] [Google Scholar]
  42. Misra V., Nelson R., Smith M. Sequence of a bovine herpesvirus type-1 glycoprotein gene that is homologous to the herpes simplex gene for the glycoprotein gB. Virology. 1988 Oct;166(2):542–549. doi: 10.1016/0042-6822(88)90525-9. [DOI] [PubMed] [Google Scholar]
  43. Murthy K. K., Calnek B. W. Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigens. Infect Immun. 1979 Nov;26(2):547–553. doi: 10.1128/iai.26.2.547-553.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Niikura M., Matsuura Y., Hattori M., Onuma M., Mikami T. Expression of the A antigen (gp57-65) of Marek's disease virus by a recombinant baculovirus. J Gen Virol. 1991 May;72(Pt 5):1099–1104. doi: 10.1099/0022-1317-72-5-1099. [DOI] [PubMed] [Google Scholar]
  45. Ono K., Takashima M., Ishikawa T., Hayashi M., Yoshida I., Konobe T., Ikuta K., Nakajima K., Ueda S., Kato S. Partial protection against Marek's disease in chickens immunized with glycoproteins gB purified from turkey-herpesvirus-infected cells by affinity chromatography coupled with monoclonal antibodies. Avian Dis. 1985 Apr-Jun;29(2):533–539. [PubMed] [Google Scholar]
  46. Patick A. K., Hinze H. C. Characterization of herpesvirus sylvilagus glycoproteins released into the culture medium of infected cells: antisera to gp13 and gp32 neutralize viral infectivity in vitro and identify antigens on plasma membranes of infected cells. J Virol. 1987 Nov;61(11):3580–3588. doi: 10.1128/jvi.61.11.3580-3588.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Riggio M. P., Cullinane A. A., Onions D. E. Identification and nucleotide sequence of the glycoprotein gB gene of equine herpesvirus 4. J Virol. 1989 Mar;63(3):1123–1133. doi: 10.1128/jvi.63.3.1123-1133.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Ross L. J., Sanderson M., Scott S. D., Binns M. M., Doel T., Milne B. Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J Gen Virol. 1989 Jul;70(Pt 7):1789–1804. doi: 10.1099/0022-1317-70-7-1789. [DOI] [PubMed] [Google Scholar]
  49. Sarmiento M., Haffey M., Spear P. G. Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity. J Virol. 1979 Mar;29(3):1149–1158. doi: 10.1128/jvi.29.3.1149-1158.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Schmaljohn C. S., Parker M. D., Ennis W. H., Dalrymple J. M., Collett M. S., Suzich J. A., Schmaljohn A. L. Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins. Virology. 1989 May;170(1):184–192. doi: 10.1016/0042-6822(89)90365-6. [DOI] [PubMed] [Google Scholar]
  51. Sithole I., Lee L. F., Velicer L. F. Synthesis and processing of the Marek's disease herpesvirus B antigen glycoprotein complex. J Virol. 1988 Nov;62(11):4270–4279. doi: 10.1128/jvi.62.11.4270-4279.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Sullivan V., Smith G. L. Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody. J Gen Virol. 1987 Oct;68(Pt 10):2587–2598. doi: 10.1099/0022-1317-68-10-2587. [DOI] [PubMed] [Google Scholar]
  53. Sullivan V., Smith G. L. The herpes simplex virus type 1 US7 gene product is a 66K glycoprotein and is a target for complement-dependent virus neutralization. J Gen Virol. 1988 Apr;69(Pt 4):859–867. doi: 10.1099/0022-1317-69-4-859. [DOI] [PubMed] [Google Scholar]
  54. Thorley-Lawson D. A., Poodry C. A. Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo. J Virol. 1982 Aug;43(2):730–736. doi: 10.1128/jvi.43.2.730-736.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Velicer L. F., Yager D. R., Clark J. L. Marke's disease herpesviruses. III. Purification and characterization of Marek's disease herpesvirus B antigen. J Virol. 1978 Jul;27(1):205–217. doi: 10.1128/jvi.27.1.205-217.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wells D. E., Vugler L. G., Britt W. J. Structural and immunological characterization of human cytomegalovirus gp55-116 (gB) expressed in insect cells. J Gen Virol. 1990 Apr;71(Pt 4):873–880. doi: 10.1099/0022-1317-71-4-873. [DOI] [PubMed] [Google Scholar]
  57. Whalley J. M., Robertson G. R., Scott N. A., Hudson G. C., Bell C. W., Woodworth L. M. Identification and nucleotide sequence of a gene in equine herpesvirus 1 analogous to the herpes simplex virus gene encoding the major envelope glycoprotein gB. J Gen Virol. 1989 Feb;70(Pt 2):383–394. doi: 10.1099/0022-1317-70-2-383. [DOI] [PubMed] [Google Scholar]
  58. Willey D. E., Cantin E. M., Hill L. R., Moss B., Notkins A. L., Openshaw H. Herpes simplex virus type 1-vaccinia virus recombinant expressing glycoprotein B: protection from acute and latent infection. J Infect Dis. 1988 Dec;158(6):1382–1386. doi: 10.1093/infdis/158.6.1382. [DOI] [PubMed] [Google Scholar]
  59. Zarling J. M., Moran P. A., Brewer L., Ashley R., Corey L. Herpes simplex virus (HSV)-specific proliferative and cytotoxic T-cell responses in humans immunized with an HSV type 2 glycoprotein subunit vaccine. J Virol. 1988 Dec;62(12):4481–4485. doi: 10.1128/jvi.62.12.4481-4485.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Zarling J. M., Moran P. A., Burke R. L., Pachl C., Berman P. W., Lasky L. A. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. J Immunol. 1986 Jun 15;136(12):4669–4673. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES